Geode Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.72M | Buy |
|
|||||
|
2025
Q1 | $1.79M | Buy |
|
|||||
|
2024
Q4 | $3.68M | Sell |
|
|||||
|
2024
Q3 | $7.91M | Buy |
|
|||||
|
2024
Q2 | $7.37M | Buy |
|
|||||
|
2024
Q1 | $14M | Buy |
|
|||||
|
2023
Q4 | $6.97M | Buy |
|
|||||
|
2023
Q3 | $3.76M | Buy |
|
|||||
|
2023
Q2 | $8.31M | Buy |
|
|||||
|
2023
Q1 | $9.19M | Buy |
|
|||||
|
2022
Q4 | $15.8M | Buy |
|
|||||
|
2022
Q3 | $33.6M | Buy |
|
|||||
|
2022
Q2 | $36.3M | Sell |
|
|||||
|
2022
Q1 | $57.2M | Buy |
|
|||||
|
2021
Q4 | $83.4M | Buy |
|
|||||
|
2021
Q3 | $83.2M | Sell |
|
|||||
|
2021
Q2 | $123M | Buy |
|
|||||
|
2021
Q1 | $111M | Buy |
|
|||||
|
2020
Q4 | $105M | Buy |
|
|||||
|
2020
Q3 | $44.1M | Buy |
|
|||||
|
2020
Q2 | $35.4M | Buy |
|
|||||
|
2020
Q1 | $21.1M | Buy |
|
|||||
|
2019
Q4 | $17.2M | Buy |
|
|||||
|
2019
Q3 | $12.6M | Buy |
|
|||||
|
2019
Q2 | $16.3M | Buy |
|
|||||
|
2019
Q1 | $13.9M | Buy |
|
|||||
|
2018
Q4 | $9.01M | Buy |
|
|||||
|
2018
Q3 | $8.39M | Buy |
|
|||||
|
2018
Q2 | $5.14M | Buy |
|
|||||
|
2018
Q1 | $3.95M | Buy |
|
|||||
|
2017
Q4 | $2.12M | Buy |
|
|||||
|
2017
Q3 | $1.2M | Buy |
|
|||||
|
2017
Q2 | $573K | Buy |
|
|||||
|
2017
Q1 | $543K | Buy |
|
|||||
|
2016
Q4 | $289K | Buy |
|
|||||
|
2016
Q3 | $337K | Buy |
|
|||||
|
2016
Q2 | $183K | Hold |
|
|||||
|
2016
Q1 | $194 | Sell |
|
|||||
|
2015
Q4 | $364K | Buy |
|
|||||
|
2015
Q3 | $575K | Buy |
|
|||||
|
2015
Q2 | $504K | Buy |
|
|||||
|
2015
Q1 | $154K | Buy |
|
|||||
|
2014
Q4 | $157K | Buy |
|
|||||
|
2014
Q3 | $160K | Buy |
|
|||||
|
2014
Q2 | $149K | Sell |
|
|||||
|
2014
Q1 | $231K | Buy |
|